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Abstract
Background: The majority of the promoters, their regulatory elements, and their variations in the
human genome remain unknown. Reporter gene technology for transcriptional activity is a widely
used tool for the study of promoter structure, gene regulation, and signaling pathways.
Construction of transcriptional reporter vectors, including use of cis-acting sequences, requires
cloning and time-demanding manipulations, particularly with introduced mutations.
Results:  In this report, we describe a cloning-free strategy to generate transcriptionally-
controllable linear reporter constructs. This approach was applied in common transcriptional
models of inflammatory response and the interferon system. In addition, it was used to delineate
minimal transcriptional activity of selected ribosomal protein promoters. The approach was tested
for conversion of genes into TetO-inducible/repressible expression cassettes.
Conclusion: The simple introduction and tuning of any transcriptional control in the linear DNA
product renders promoter activation and regulated gene studies simple and versatile.
Background
Transcription occurs due to many different signaling path-
ways leading to activation of transacting factors that regu-
late promoter activity. Transcriptional deregulation has
been implicated in several diseases such as cancer and
inflammatory conditions, and many transcriptional fac-
tors themselves are drug targets. For example, the NF-κB
signaling pathway has been increasingly seen as a promis-
ing target for pharmacological intervention, especially in
inflammation and cancer, where the pathway is often con-
stitutively active [1]. The Reporter assays offer an impor-
tant tool in assessing transcription and gene expression
changes due to many extra- and intracellular events
including modulation by receptor agonists, intracellular
signaling events, and inhibitor compounds. In transcrip-
tional reporter systems, cloning of promoters and inclu-
sion of transcriptional control elements such as
transcriptional factor sites and their variations, e.g., muta-
tions and insertions/deletions are time-demanding
efforts. Likewise, regulated transcriptional systems, such
as the tetracycline-resistance operon (TetO)-based system,
requires cloning of the TetO upstream or downstream of
the TATA box of a reporter or other gene product [2]. In
this report, we describe a simple cloning-free system to
construct reporter linear DNA by PCR that is transcrip-
tionally controllable and useful in transcription and regu-
lated gene studies.
A large number of transcriptional control elements, esti-
mated to be in the vicinity of 3000, their genetic varia-
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tions, and regulatory clusters (>100,000) [3-5] were
recently found due to large scale sequencing, functional
genomics, and computational prediction studies. Thus, a
need for a simplified approach as opposed to cloning and
plasmid-based techniques would be desirable. Although
high throughput applications of promoter studies have
been recently developed [6,7], there is a constant require-
ment for studying minimal transcriptional regions, to
introduce genetic variations, and to manipulate position
and arrangements of transcriptional cis-acting elements of
single or multiple genes. Here, we utilized mammalian
transfection of transcriptionally-regulatable reporter PCR
products that are generated with any variation of the tran-
scriptional control elements, i.e., by a simple and cloning-
free step. The utility of this strategy is flexible and can be
used in constructing as many as desired promoter and
transcriptional element manipulations with a larger
throughput than conventional cloning. Additionally, the
conversion of any gene in an expression vector to Tet-
inducible/repressible system without any cloning indi-
cates the notable simplicity of the described approach.
Results
Transcriptionally-Controllable Cloning-Free Reporter 
Assay
The reporter assay is dependent on amplification of a
functional reporter cassette from a vector with efficient
mammalian expression modules, e.g., strong promoter,
intron, and the bovine growth hormone (bgh) 3'UTR
(Figure 1A). When transfected as a linear product, it is suf-
ficient to express the reporter. The design of the PCR for-
ward primer, through a 3' end sequence, allows flexibility
in targeting any position in the source vector, e.g., mini-
mal promoter, while the 5' end part includes other desired
transcriptional control sequences, e.g., transcriptional fac-
tor site or its variants (Figure 1A). We have used this
approach with a number of different strategies. Each is
described here with a demonstration of its utility in sev-
eral applications of transcriptional studies, particularly in
inflammation and innate immunity models.
Inflammatory response of NF-κB-regulated PCR reporter 
product
To demonstrate the applicability of the described
approach in a commonly-studied inflammation response
model, we constructed, by a single PCR, a linear construct
using a forward primer that includes two copies of the
consensus NF-κB site and 3' end sequence that targets a
region in the CMV promoter in vector (Table 1). As a con-
trol, mutant NFκB sites were also incorporated in a differ-
ent linear construct. Thus, a PCR product was produced
containing the NFκB-responsive minimal promoter
upstream of the EGFP reporter along with a 3' UTR. After
transfection onto HEK293 cells overnight, IL-1α was
added. IL-1α increased, in a dose-dependent manner, the
EGFP reporter activity produced from the PCR product
that harbors the NF-κB-minimal promoter (Figure 1B). In
contrast, IL-1α did not upregulate any reporter activity
from the linear PCR construct made with the mutant
NFκB site (Figure 1B). There appears to be a higher (~2-
fold) constitutive activity of NF-κB when compared to
mutant NF-κB PCR products (ANOVA, p < 0.01). A five-
fold increase (Figure 1B, insert) in the transcriptional
induction was seen with the highest dose of IL-1α (10 ng/
ml), when readings were normalized to background basal
levels. There was also appreciable promoter activity (~3–
4-fold) due to NF-κB activation as assessed with fluores-
cence signals after only four hours of treatment (Figure
1C) indicating the sensitivity of the transcriptionally-
modulated linear reporter. Normalization by co-transfec-
tion with red fluorescent protein (RFP) yielded the same
results (Figure 1C, insert). The transcriptional induction
was also seen at mRNA level. IL-1α induced significant
EGFP mRNA expression (4-fold) when assayed at 4 and 6
hr post-treatment (Figure 1D).
There was a dose-dependent increase in EGFP fluores-
cence from the transfected linear PCR construct that har-
bors the two NFκB sites in response to another pro-
inflammatory cytokine, TNF-α (Figure 1E). A maximal
response of 6-fold increase was seen with 3 ng/ml of TNF-
α. As with IL-1α, the transfected linear PCR products that
incorporate mutant NFκB were not responsive to TNF-α
(data not shown).
Dynamic response of promoter activity from PCR reporter 
products
Enhanced dynamic response to the cytokines can be
improved by varying the minimal reporter region and
copies of the response elements (Figure 2A). Using a for-
ward primer of the PCR to target further minimal region
of CMV promoter (-53) fused with four copies of NF-κB
sites led to higher stimulation ratios (14–18 fold;
ANOVA, p < 0.001) from the transfected PCR products
when compared to PCR products with 2 copies of NF-κB
and -95 minimal CMV promoter (Figure 2B).
In order to further evaluate the difference in response of
reporter plasmids versus the reporter PCR product, both
dynamic response and absolute expression levels were
evaluated. The dual firefly/renilla-normalized luciferase
pGL3 system was performed using the transfected PCR
product or the source plasmid each harboring three copies
of NFκB. Though the absolute expression levels of the
reporter expressed from PCR products were lower (expect-
edly) than those from the plasmid, the levels were still sig-
nificant and quantifiable (Figure 2C). More importantly,
the dynamic and specific response of the linear reporter
PCR product is superior than the plasmid. TNF-α caused
enhnaced response of the NFκB in case of the NfκB-har-BMC Molecular Biology 2009, 10:20 http://www.biomedcentral.com/1471-2199/10/20
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Schematic representation of the cloning-free reporter construction and assay and use in inflammation model Figure 1
Schematic representation of the cloning-free reporter construction and assay and use in inflammation model. 
(A) An expression plasmid harboring a reporter cDNA is used as a template for PCR. Forward primer sequence contains 3' 
end that targets a minimal promoter region and 5'end that accommodates cis-acting sites. The reverse universal primer targets 
a region downstream of the polyA site. Purified PCR products are transfected into mammalian cells to express the 
reporter.(B) HEK293 cells in 96-well plates were transfected with 75 ng of purified PCR products in which the forward primer 
contains two copies of NF-κB site or a mutant form (Table 1, SEQ 1 and 2). After 20 hr, the cells were treated with IL-1α 
(log0.5) for additional 20 hrs. (B, insert). Dose-response relationships between IL-1 and NF-κB mediated GFP reporter activity 
(normalized to basal levels of mutant NF-κB reporter levels). (C) EGFP activity was measured after 4 hr of IL-1 treatment with 
or without normalization (insert) with non-responsive RFP-PCR product. All data above are Mean ± SEM (quadruplicate) of 
one of three experiments. **p < 0.01, *** < 0.001. (D) Total RNA was extracted from HEK293 cells that were transfected 
with NF-κB responsive or mutant NF-κB-bearing PCR products in the absence or presence of IL-α (10 ng/ml) for 4 or 6 hrs. 
RT-PCR was performed using primers specific to EGFP as described in Methods. PCR products were run on gel, and β-actin 
normalized signal intensities of ethidium bromide-stained products were quantitated using AlphaEase software. Data are from 
three experiments.(E) Dose-dependent curve of TNF-α action on reporter activity produced from NF-κB responsive linear 
PCR construct.
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boring PCR product when compared to mutant NFκB, in
contrast to the plasmid (Figure 2C). Treatment of either
IL-1α or TNF-α, caused specific and higher dynamic
response (ANOVA, p < 0.001) of the luciferase reporter
generated from the PCR product when compared to the
plasmid (Figure 2D).
The transfection efficieny was evaluated using GFP fluo-
rescence and cell count (on Hoechst dye background); the
transfection efficiency of the PCR product (80% ± 10) was
comparable to that of the plasmid transfection (85% ±
10) in HEK293 cell line-Similar results were obtained
with flow cytometry. However, expression levels, as with
the luciferase, were lower with the PCR product when
compared to the plasmid but they are significantly quan-
tifiable. Fore example, the fluorescence levels were 670 ±
14 million pixels per 104 cells transfected with the plas-
mid while in case of PCR products the fluorescence levels
were in the range vicinity of 200 ± 10 million pixels per
104 in HEK293. Using a flow cytometry experiment, the
mean value of fluorescence released from linear PCR
product was 3741 and from the plasmid was 5666 in HEK
cells.
Promoter activity from metal- and interferon responsive 
PCR reporter product
The cloning-free approach (Figure 3A) was easily applied
to generate a PCR product expressing EGFP reporter under
the control of metal responsive element (MRE)-mediated
transcription. Minimal metal response elements [8] that
belong to metallothioneins promoters, MT1F and MT1G
(Table 1), were included in the Forward primer. The heavy
metal, cadmium, was used to upregulate the transcription
of the MRE-containing minimal promoter from the trans-
fected EGFP reporter PCR product (Figure 3A). At 10 uM
of cadmium, response from MT1F, which contains three
MRE sites was stronger than that of MT1G, which has two
MRE sites. However, at 20 uM, both MREs mediate similar
responses.
A minimal IFN-response element (ISRE) from the IFN-
stimulated gene, ISG56 (IFIT1) [9] was incorporated in
the forward primer of the PCR. IFN-α was able to induce
the transcriptional activation of the transfected linear
EGFP PCR product that contains the ISRE-containing
minimal promoter, in the IFN-sensitive Huh7 cell line
(Figure 3B). In contrast, the transcriptional activation by
IFN-α from the ISRE-bearing PCR cassette was not
observed in a Stat1 response-deficient cell line, 293 clone
(Figure 3B, right panel). As low as 0.3 U/ml was able to
induce reporter activity due to transcriptional stimulation
by IFN. Maximum stimulation (~5-fold) was observed at
33 U/ml of IFN-α (Figure 3C). At mRNA levels, IFN
strongly induced ISRE-responsive reporter activity from
the transfected PCR product at 4 hrs post-treatment (Fig-
ure 3D).
Table 1: Sequences in forward primers used for generation of the transcriptionally-regulatable PCR products
SEQ Forward Primer PCR product will contain I-TFS
15 '  A G GGGACTTTCCTGAGTCAATAGGGACTTTCCAATGCCAAAATGT 
CGTAACAACTC3'
NF-κB responsive Minimal Promoter NF-κB
2 5' AGGCGACTCTCCTGAGTCAATACTCACTCT 
CCAATGCCAAAATGTCGTAACAACTC3'
Mutant NF-κB/Minimal Promoter NF-κB mutant
3 5'CAATAGGGACTTTCCCATGGGACTTTCCCAGGGGACTTTCCT
GAGTCAATAGGGACTTTCCAATGGGTAGGCGTGTACGGTG3'
NF-κB (4×) responsive Minimal Promoter (-53) NF-κB 4×
4 5' CTGCGCTCAGGGGACCTTGCGCCCGGCCCTTCTGCTGCA 
CACAGCCCACCCCAAAATGTCGTAACAACTC3'
Metal response Minimal Promoter MT1F-MRE
5 5'ACTCAGCGGGCTGGGTGCAAGGGCGGGGCGGGGCGTCTGC
GCCCGGCCCCGCCAAAATGTCGTAACAACTC 3'
Metal response Minimal Promoter MT1G-MRE
65 '  A G CTTTAGTTTCACTTTCCCCTTTCGGTTTCCCTAGGTTTCCAACC 
AATGCCAAAATGTCGTAACAACTC3'
IFN-responsive Promoter ISRE
7 5' CTTGGGGCGGGGCTGCGGAGATCTCGCGGCGCTTGGCGTG 
CTATAAAAGCAGAGCTCGTTTAGTGA3'
RPS2 Minimal Promoter -
8 5' GAAGGCACTAGAAGAGGCGGTCGGTGCATAGCGTCACCTC 
CTAAACTCGCAGAGCTCGTTTAGTGA3'
RPL39 Minimal Promoter -
9 5'GTAAATGACATAGGAAAACTGAAAGGGAGAAGTGAAAGT 
GGGAAATTCCTCTGAATAGAGAGAGGACCATCTCATATAAATA
GCAGAGCTCGTTTAGTGA3'
Minimal virus-induced IFNB prom. VRE
10 5'ACCAGGTCCCTATCAGTGATAGAGATCCTCCCTTCAGTGA 
TAGAGACCAAAATGTCGTAACAACTC3'
TetO2-Minimal Promoter (-95) TetO
11 5'ACCAGGTCCCTATCAGTGATAGAGATCCTCCCTATCAGTG 
ATAGAGAGGTAGGCGTGTACGGTG3'
TetO2-Minimal Promoter (-53) TetO
12 5'CATCCCTATCAGTGATAGACCATCCCTATCAGTGATAGAC 
CATCCCTATCAGTGATAGACGGTAGGC GTGTACGGTG3'
TetO3-Minimal Promoter (-53) TetO
The reverse universal primer targets a region downstream of the polyA site.
I-TFS: inducible transcriptional factor sites (italics).
Underlined is the 3' end region of the primer complementary to the vector template.
The minimal promoter of SEQ 1–6 and 10–12 is derived from CMV minimal promoter (Figure 3B).BMC Molecular Biology 2009, 10:20 http://www.biomedcentral.com/1471-2199/10/20
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Evaluation of minimal constitutive and inducible 
sequences
A variation of our approach was used to examine minimal
promoter regions (Figure 4A). A minimal promoter
sequence of interest can be incorporated in the forward
primer, whereas the 3' end of the forward primer anneals
to a region upstream of the reporter cDNA. In our case, the
region is exon 1 (5'UTR) downstream of the CMV pro-
moter. This strategy was applied by evaluating the previ-
ously uncharacterized promoters of ribosomal proteins,
RPS2 and RPL39, and comparing them with the CMV
minimal promoter as a control (Figure 4B). The CMV
minimal promoter was the strongest, as expected. The
RPL39 had weaker constitutive activity when compared to
RPS2 (Figure 4C).
We also tested an inducible minimal promoter of IFNB1,
which possesses virus response inducible element (VRE)
[10], and was entirely incorporated in the Forward primer
of the PCR (Figure 4B, lower panel). The IFNB promoter is
inducible with the double-stranded RNA, poly (I.C.), a
viral intermediate mimic. The HEK293 cells, which are
known to lack TLR-3, are not responsive to poly (I.C.)
[11], thus, we used TLR-3 over-expressing HEK293 cell
line. Here, poly (I.C.) was able to increase the minimal
IFNB promoter by 5-fold in HEK293 cells that over-
express TLR3 (Figure 4D). There was a basal level of IFNB
Dynamic response of the activity of reporter expressed from PCR product Figure 2
Dynamic response of the activity of reporter expressed from PCR product. (A) The reporter expression plasmid 
was used as a template for PCR in which the forward primers target either -53 or -95 sequences of the CMV promoter and 
includes two or four copies of NF-κB or a mutant NF-κB control (Table 1, SEQ. 1–3). (B) Fluorescence levels from EGFP 
PCR products that contain two, four, or mutant copies of NF-κB were quantitated as described above.(C) HEK293 cells were 
transfected with either NfκB-firefly luciferase expression vector or purified PCR products that were amplified from the luci-
ferase vector and co-transfected with Renilla luciferase expression vector. Empty DNA represent either the vector or the PCR 
product without the inserted NF-κB sequence. The cells were treated with either IL-1α or TNF-α for 4 hrs as previously 
described. Luciferase activity levels were quantified by a luminometer and either absolute expression levels (C) or fold increase 
over control (no treatment) are shown (D). Data are Mean ± SEM. *p < 0.05, *** p < 0.001.
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promoter which is likely due to over-expression of TLR3,
but was further attenuated with the use of lower input of
the reporter construct (Figure 4D).
Cloning-free conversion of genes into inducible-repressible 
expression cassettes
The EGFP expression vector was used as a template to gen-
erate a Tet-Off/On linear cassette by the single PCR
method (Figure 5A). Linear constructs were generated by
PCR that contains different TetO copies and minimal pro-
moter arrangements. The design of the forward primer,
through 3' end sequence, allows flexibility in choosing the
minimal sequences of the CMV promoter. The targeted
regions are either -53 or -95 bases upstream of the site of
transcription in the source DNA while the 5' end part
allows inclusion of two or more copies of the TetO
(Table 1). The PCR products are transfected into a HeLa-
Tet off cell line that constitutively expresses the transacti-
Generation of metal and IFN-responsive reporter PCR products and their performance Figure 3
Generation of metal and IFN-responsive reporter PCR products and their performance. (A) HEK293 cells in 96-
well plates were transfected with 75 ng of purified PCR products generated from reporter vector using the Forward primer 
that contains MRE sites (Table 1, SEQ. 4 and 5). After 20 hr, the cells were treated with 10 μM cadmium for 16 hrs. Data is 
Mean ± SEM (quadruplicate) – a representative experiment of two- of fold increase due to cadmium in GFP fluorescence levels 
that were normalized to background fluorescence from non-MRE PCR product. (B) Huh7 cells in 96-well plates were trans-
fected with 75 ng of purified PCR products in which the Forward primer includes two putative ISRE sites (Table 1 SEQ 6). After 
approximately 20 hr, the cells were treated with IFN-α (log0.5) for an additional 16 hrs. Right panel: An IFN-resistant HEK293 
cells were transfected with the ISRE-containing EGFP PCR product (20 hr) and then treated with IFN-α (33 IU/ml) for 16 hr. 
Data are from one experiment (Mean ± SEM (n = 4). (C) Dose-response curve for IFN action on GFP reporter activity from 
the ISRE-containing PCR product (normalized to fluorescence levels from non-responsive reporter). *, p < 0.01, **p < 0.005 
and ***p < 0.0001. (D) Total RNA was extracted from Huh7 cells that were transfected with IFN-responsive reporter PCR 
products in the presence or absence of IFN-α (100 U/ml) for 4 or 6 hrs. RT-PCR was performed using primers specific to 
EGFP as described in Methods. PCR products were run on gel, and β-actin normalized signal intensities of ethidium bromide-
stained products (Mean ± SEM (n = 3) were quantitated using AlphaEase.
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Cloning-free construction and evaluation of de novo minimal promoters Figure 4
Cloning-free construction and evaluation of de novo minimal promoters. (A, B) The reporter expression plasmid 
was used as a template for PCR. Forward primer contains at 3' end, 18 bases that target 5'UTR (exon 1 of the CMV IE gene) 
upstream of reporter cDNA and 5' end sequence representing 48 bases derived from CMV (control), RPS2, RPL39 promoters 
or the minimal inducible IFNB promoter (Table 1, SEQ 7–9). The reverse universal primer targets a region downstream of the 
polyA site. (C) The resultant and purified PCR products were transfected onto HEK293 cells. After 48 hrs, the GFP fluores-
cence was quantitated as outlined in the Figure 1 legend.(D) TLR-3 stably transfected HEK293 cells (TRL3+) or control (TLR3 
negative) HEK293 cells were transiently transfected with IFNB minimal promoter-harboring PCR products and were treated 
with or without 25 μg/ml of poly I. C. Fluorescence levels were quantitated after 20 hr as described above.
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vator, tTA. In the presence of the tetracycline analog, dox-
ycycline, tTA is inactive. In the absence of doxycycline, the
tTA is active, and binds TetO containing promoter and
thereby activates transcription of the linked gene. The
TetO2-minimal promoter (-53) containing construct had
slightly increased suppression in the presence of doxycy-
cline when compared to the construct with extended (-95)
minimal promoter (Figure 5B). The transfected PCR prod-
ucts with three copies of TetO resulted in greater repres-
sion (71%) compared to those with two TetO copies
(~57%; Figure 5B). Doxycycline has no effect on EGFP lin-
ear control constructs that lack TetO sequences (Figure
Cloning-free conversion of genes into inducible-repressible expression cassette Figure 5
Cloning-free conversion of genes into inducible-repressible expression cassette. (A) Schematic representation of 
the cloning-free conversion of a gene product into tetracycline-inducible gene. Forward primer contains 3' end sequences that 
targets a minimal region in the vector template and 5'end that contain two or three copies of TetO sites (Table 1, SEQ. 10–
12). Reporter-C' MODC denotes unstable EGFP version that was created by fusing EGFP with MODC C-terminus as 
described in Methods. (B) HeLa Tet-off cells in 96-well plates were transfected with 75 ng of PCR products generated from 
reporter vector (A) and subsequently treated with or without 0.1 ug/ml of doxycycline for 26 hr. As a control, EGFP PCR 
product which lacks TetO was used. Arrows denotes % reduction. (C) Purified PCR products amplified from expression vec-
tors that contain either wild type EGFP or unstable EGFP were transfected onto HeLa Tet-off cells in the presence or absence 
of 0.1 ug of doxycycline for 26 hrs. Data in B and C are Mean ± SEM (quadruplicate) from a representative experiment of 
three. (D) Representative images of the effect of doxycycline on the TetO-containing reporter expression PCR products with 
or without normalization of RFP-expressing PCR product that lack TetO sites. Images represent single (I) or co-transfection 
(II) experiments. (E) HeLa Tet-off cells were transfected with purified PCR products that were amplified from TTP expression 
vector with TetO2 forward primer (Table 1, SEQ. 11) and polyA reverse primer, in the absence or presence of 0.1 ug/ml of 
doxycycline. Western blotting using anti-body to TTP and GAPDH was performed. V denotes vector only.
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4B). The moderate reduction of the EGFP is likely due to
the long half life of EGFP. Subsequently, we rendered
EGFP unstable by fusing with mouse ornithine decarbox-
ylase (MODC) domain leading to shorter half life (<4 hr).
There was almost complete (98%) repression (ANOVA, p
< 0.001 Bonferrino post test) with the unstable EGFP
when compared to the wild type GFP (66% repression)
(Figure 5C). Both TetO2 and TeO3 yielded the same results
(97–98% suppression, p < 0.001) in case of the unstable
EGFP (Figure 5C). Doxycycline also had no effect on
either stable (Figure 5B, right columns) or unstable EGFP
that lacks TetO sites (Data not shown). Representative
images of TetO-regulated experiments are shown with and
without of RFP-normalized quantitation (Figure 5D) indi-
cating that, in general, normalization is not needed as
shown previously in Figure 5C. Further, we use the TeO
PCR-mediated conversion approach to turn off the
ectopic expression of the RNA binding protein, tristetrap-
roline (TTP). The HeLa tet-off cells which lack any detect-
able TTP protein expressed TTP from the transfected PCR
product that was amplified in a similar manner as the
reporter. Addition of doxycycline completely turned off
TTP expression (Figure 5E). Converting any reporter or
gene product into a tunable TetOn-Off expression system
with a single PCR is evidence of the remarkable simplicity
of the described approach.
Discussion
Monitoring gene expression in a number of applications
using reporter genes is a widespread research tool. The
described approach provided a reporter technology for
manipulating promoter and transcriptional regulatory
elements, including introduced mutations and genetic
variations, without the need for the time-demanding
cloning steps. The ease of making these linear reporter
constructs and simplicity of introducing the desired regu-
latory sequences, make this reporter technology versatile
and amenable to high-throughput applications. The per-
formance of the described technology is reproducible
with various combinations of promoters, reporters (here,
EGFP and luciferase), cis-acting elements, minimal pro-
moters, cell lines, and inducers. Furthermore, the
described cloning-free concept was applied to a regulated
gene system, specifically, the TetO inducible/repressible
expression system.
The CMV minimal promoter was used in conjunction
with several cis-acting elements, namely, NF-κB, ISRE,
MRE, VRE, and TetO. NFκB is a member of the rel family
of transcription factors that regulates several important
physiological processes, including immune responses,
inflammation, cell growth, apoptosis and tumorigenesis.
Many different stimuli have been identified that activate
the NF-κB pathway such as the pro-inflammatory
cytokines TNF-α and IL-1. Both cytokines increase the
reporter activity from the transfected NF-κB-regulatable
PCR product generated by the described technology. Since
many tumor cell lines are high in NF-κB activity [12], we
have observed higher reporter activity in the cell line used
in case of the NF-κB-regulated, but not the NF-κB mutant
harboring linear construct.
In most of the experiments, only two copies of either NF-
κB or ISRE were assessed, giving response in the vicinity of
five fold. The response of the reporter assay can be
improved through the use of multiple copies of the cis-
acting elements [13] and use of de-stabilized forms of
reporters [14,15]. Additionally, the minimal CMV pro-
moter region can be attenuated if the target region of the
forward primer is downstream towards the TATA box. A
forward primer with four copies of NF-κB that also target
-53 of CMV minimal promoter region results in enhanced
reporter response to the cytokines (e.g., Figure 1h and 4b).
This feature of the variable positioning of the target region
of the forward primer allows versatile manipulation of
transcriptional control elements of any promoter and pro-
duction of a PCR product harboring the desired variation.
The method was applied in another cellular model, IFN
response, by incorporating the ISRE of the strong IFN-
responsive ISG56 gene (IFIT1)[9]. ISRE is a consensus
sequence that exists in the promoter of IFN-stimulated
genes and binds certain members of the IFN-regulatory
factors (IRF) [16]. The IFN response of the transfected
ISRE-controllable linear PCR product was observed in the
IFN-sensitive Huh7 cell line but not in the 293 cell clone.
This cell line clone is resistant to IFN at doses ≤ 100 U/ml
[17].
Many of the genes in humans and other organisms are of
unknown function, and evaluation of their promoters
offers valuable information. Also, mapping of minimal
promoter regions of complex gene structures and rear-
rangements requires a versatile approach. The ability to
evaluate any sequence of interest for the ability to elicit
the reporter transcription using the described PCR strategy
is of notable application. We have used this approach to
evaluate the differential ability of the minimal promoter
sequence of RPS2 and RPL39 to induce the reporter activ-
ity. The RPL39 minimal promoter which lacks both the
typical TATAAA signal and SP1 site when compared to
RPS2, although it possesses TAAA, has weaker constitutive
reporter activity when compared to RPS2. An entire mini-
mal IFNB inducible sequence [10] was incorporated into
the forward primer of the PCR and was responsive in
TLR3-expressing 293 cell line but not in 293 cells that do
not express the TLR3 gene and thus is not responsive to
the viral intermediate mimic, poly (I.C.) [11].BMC Molecular Biology 2009, 10:20 http://www.biomedcentral.com/1471-2199/10/20
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Although any reporter can be employed with this
approach, we mainly used the EGFP system. We also used,
but to a lesser extent, the luciferase system. Particularly
when coupled with advanced imaging processing, the
EGFP is sensitive and has a large dynamic range. Use of
fluorescent reporters have several advantages including
repeated measurements in live cells, single cell assess-
ment, reduced variability and ease due to the absence of
cell lysis. The EGFP reporter assay resulted in intra-well
variance in fluorescence that was mainly <6%, which does
not warrant intra-well normalization of transfection [18],
although some of the experiments utilized red fluorescent
protein (RFP) for the purpose of confirming this normal-
ization feature. There are many recent improvements in
fluorescent proteins and their biophysical characteristics
that render them more sensitive (brighter) and with differ-
ent colors [19] that can also be used with the described
approach.
The most important feature of the described method here
is the enhanced applicability since it involves no cloning.
An additional advantage of the use of PCR products in
contrast to plasmid in transfection is the absence of plas-
mid preparation. Although, transfection with PCR prod-
ucts is generally less efficient than with plasmids,
successful results are obtained with optimized expression
cassettes [18,20], particularly when coupled with a sensi-
tive reporter system and use of advanced image segmenta-
tion methods as in the case of fluorescent proteins. Other
added advantages are lower cellular toxicity and extended
expression [18,20,21].
Further advantages of the reporter PCR method is attrib-
uted to lack of certain characteristics that commonly
encountered with plasmids use in gene and reporter
expression studies, namely, cryptic transcription and
supercoiling-quality variations. The elimination of the
plasmid backbone may results in reduction of cryptic
transcriptionally active sequences that normally found in
the plasmid backbone [22] leading to more specific and
larger dynamic response. Supercoiling in general is known
to have positive effect on transcription, and supercoiled
plasmids may be more efficient for transient mammalian
gene expression when compared to linear DNA; however,
there are reports that show that this is promoter-specific,
and supercoiling effect was not seen with certain promot-
ers [23,24]. Thus, the use of the PCR products at least min-
imizes the variations of supercoiling quality of plasmids.
A limitation is that only short transcriptional regions
(<150 bases) of a large promoter can be studied. However,
most of the regulatory cis-acting elements are typically
short of 5–15 bases [5] and transcriptional studies rely on
smaller regions that can be accommodated with the tar-
geting position and length of the oligonucleotides. More-
over, additional PCR reactions can append additional
promoter regions as required. Studies with deletion pro-
moter mutants can also benefit from the cloning-free
strategy by designing primers that target sequential
regions of the promoter.
Converting any gene product from an expression vector
into an inducible/repressible expression linear construct
is made possible by the cloning-free linear DNA construc-
tion. In this study, we utilized the common TetO system
in which the tetracycline-responsive TetO elements are
regulated by the repressor, rtTA, or the activator protein,
tTA the Tet-On and Tet-Off systems [2]. Significant leak-
age reduction and gene repression was achieved by the
TetO-PCR product transfection, particularly with the use
of unstable EGFP and three copies of TetO leading to total
repression.
Conclusion
This study reports several cloning-free strategies to gener-
ate transcriptionally-regulatable PCR products that when
transfected express measurable reporter activity. There are
many other variations and subsequently versatile applica-
tions for the described approach. Tunable manipulations
in gene and reporter expression such as the number of
transcriptional element copies, mutations, gene destabili-
zation elements, and minimal region are made straight-
forward by the described approach. The versatility and
ease of making the linear reporter constructs for transcrip-
tional studies should make this approach widely used and
suitable for high throughput applications. This cloning-
free system is utilized to fine tune the transcriptional con-
trol of any gene of interest and it makes transcriptional
assessment studies and converting genes into inducible/
repressible systems a simple task.
Methods
Cell lines and inducers
HEK293 was obtained from American Type Culture Col-
lection (ATCC; Rockville, MD) and cultured in RPMI
1640 (Invitrogen, Carlsbad, CA) supplemented with 10%
FBS and antibiotics. Huh-7 cells were obtained from Dr.
Stephen Polyak (University of Washington, Seattle, WA)
and propagated in DMEM medium with 10% FBS and
antibiotics. The TLR-3 over-expressing HEK293 cell line
was purchased from Cayla-Invivogen (France). HeLa-Tet
off cell line which stably expresses tTA was obtained from
Clontech, Inc. (Mountain View, CA) and was grown in
DMEM medium using Tet-approved serum (Clontech)
and maintained with the selection drug, G418. Recom-
binant human IL-1α and TNF-α were obtained from R &
D systems (Minneapolis, MN) and Human rIFN-a2a (Rof-
eron) was from Hoffman-LaRoche, Basel, Switzerland and
had specific activity of 2 × 108 IU/mg. Cadmium sulfateBMC Molecular Biology 2009, 10:20 http://www.biomedcentral.com/1471-2199/10/20
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and poly(I.C.) were purchased from Sigma (St Louis,
MO). Doxycycline was obtained from Sigma.
Plasmids, plasmid constructions
The EGFP-Gwiz plasmid which is under the control of
CMV/Intron A was obtained from Genelantis (San Diego,
CA). The same plasmid backbone was used to construct
other forms of reporters. The wild type EGFP was rendered
unstable by fusing with the amino acids 422–461 of the
degradation domain of mouse ornithine decarboxylase
(MODC). Briefly, the MODC domain was amplified from
genomic DNA of mouse fibroblasts using specific primers
that contain EcoRI and BamH1 sites in the forward and
reverse primer, respectively. The amplified cDNA was
cloned in frame with EGFP coding region using the same
restriction sites. The RPF-Gwiz plasmid was constructed
by first amplifying RFP cDNA from TurboRFP (Evrogen,
Russia) with primers containing SalI and BamHI sites in
the forward and reverse primer, respectively. Subse-
quently, the amplified RFP cDNA was cloned into Gwiz
plasmid that was previously cut with SalI and BamH1
sites. Constructs were verified by both sequencing and
expression. TTP cDNA was excised from bluescript vector
(obtained from Dr. Perry Blackshear, NIH) and cloned
into a pcDNA3.1 vector. The pGL3-NfκB was obtained
from Dr. M. Dehbi (King Faisal Specialist Hospital and
Research Center), it contains 3 copies of NfκB cloned into
pGL3 using NheI-XhoI sites upstream of minimal SV40
promoter.
Expression Active reporter PCR
The expression active PCR products were generated
directly from the vector using two primers, a forward
primer that targets vector sequences (See Oligonucle-
otides below) and a reverse primer that is complementary
to a downstream region of the poly(A) site. The latter is as
follows: 5' CCA TAG AGC CCA CCG CAT 3'. The PCR is
generated from template that is not complex, i.e., plasmid
DNA, the PCR -also with annealing temperature of 51°C.
Thus it is straightforward and robust with the forward
primer that has 17–19 bases of complementary sequence
to the plasmid template. PCRs were carried out using the
following reagents and conditions: 2.5 U HotStart Taq
(Qiagen) and 0.2 U Pfx polymerase (Invitrogen, Carlsbad,
CA) mix, 2 μl (100–200 ng) of the vector template, 1×
PCR buffer, 0.2 mM dNTPs, 0.2 μM primers, with the fol-
lowing cycle conditions: 95°C for 12 min, 31 cycles of:
94°C, 1 min., 51°C, 1 min., 72°C, 4 min., and final
extension at 72°C for 7 min. The PCR products were puri-
fied using Qiagen PCR purification columns to eliminate
the primers, small PCR products, buffer, and enzymes.
The PCR products were finally eluted in sterile water. The
typical yield of purification is 0.2 ug/ul in a volume of 30
ul. The PCR products were run on a 1.2% agarose gel and
visualized by ethidium bromide under UV light to verify
size and quality.
Oligonucleotides (Forward Primers)
The forward primer used for reporter expression active
PCR contains 3' end sequences (~18 bases) complemen-
tary to a desired region in the vector template upstream of
the EGFP coding region and 5' end sequences that accom-
modate any further described transcriptional control ele-
ments (Table 1). HPLC-purified oligonucleotides were
custom-synthesized by Metabion (Germany).
Transfection experiments
Cells were grown at standard culture conditions (37°C,
5% CO2). 3 × 104 cells per well in 96-well clear-bottom
black plates (Matrix technologies, Hudson, NH) were
transfected with purified reporter linear constructs (PCR
products). Transfections were performed in serum-free
medium using Lipofectinamine 2000 (Invitrogen). All
transfections were performed in several replicates as indi-
cated in the text. The variance in GFP fluorescence among
replicate microwells was < 6%; thus, with this minimum
variance, experiments do not warrant transfection nor-
malization [18]. Data are presented as mean values ±
standard error (SEM). Western blotting of the transfected
cell line was used in the case of the RNA binding protein,
TTP, and GAPDH. Rabbit anti-TTP antibody was obtained
from Santa Cruz, CA, and used at 1/500. Secondary HRP-
conjugated antibody (1/1000) was used.
Luciferase assay
Cells were grown at 3 × 104 cells per well in 96-well plates
and were transfected with purified reporter linear con-
structs (PCR products). After treatment, cells were har-
vested by aspiration of the media followed by the
addition of lysis buffer (Promega) per well and transferred
to an opaque 96-well plate. Luciferase assays were per-
formed using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer's instructions
and measured on a ZENYTH 3100 luminometer. Data are
presented as fold increase over basal levels according to
the readings of Mean ± SEM of luminescence.
Semi-Quantitative PCR
Total RNA was extracted using Trizol method. RT reaction
was performed using 200 ng total RNA, 500 ng oligo
dT(18–23), 500 mM dNTP mixture, 20 U RNAsin (Pharma-
cia), 200 U of SuperScript II (Invitrogen). Hot start PCR
amplification was performed using HotStart Taq DNA
polymerase (Qiagen). The cDNA was amplified at opti-
mum cycle number according to an amplification curve of
EGFP and β-actin cDNA that was determined for each
cDNA of interest by plotting increasing cycle numbers
against ethidium bromide stained gel intensity of the
amplified products. Cycling was 94°C for 60 s, 60°C for
30 s, and 72°C for 60 s using primers specific to EGFP
mRNA and β-actin mRNA. The EGFP primers are forward:
5' CCACGCTGTTTTGACC TCCA3' and reverse primer: 5'
CACCCTCTCCACTGACAGAGA 3' which give PCR prod-BMC Molecular Biology 2009, 10:20 http://www.biomedcentral.com/1471-2199/10/20
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uct of 230 bases. The β-actin forward primer is 5' ATCT-
GGCACCACACCTTCTACAATGAGCTGC G3' and the β-
actin reverse primer: 5' CGTCATACTCCTGCT TG CTGA
TCCACA3'. Both primer pairs were designed to span
intronic sequences so that the larger PCR products due to
genomic DNA contamination are not favored in amplifi-
cation. Quantitation of ethidium bromide-stained signals
on agarose gels were performed by AlphaEase software
(Alpha Innotech, San Diego, CA).
Imaging fluorescence measurement and quantitation
Efficiency and level of transfection was aided by monitor-
ing the fluorescence from EGFP constructs (optimum
excitation wavelength: 488 nm and emission wavelength:
503 nm). Pictures were taken automatically using BD
high-throughput imaging system, BD Pathway 435 (BD
Biosciences, Europe. In all cases, exposure intensity and
duration, PMT gain, and other settings were kept constant
to allow equal comparison of experiments. Auto-focus of
the instrument was performed for each image in 2 × 2
montage. Automated identification of cell regions was
performed using improved in-house software, ProXcell.
The green o red bands of the captured color images of cells
consisting of ~1344 × 1024 pixels were processed as fol-
lows. The images were divided into four quadrants and
each quadrant was processed and analyzed separately to
speed up the process. Morphological opening process was
utilized to obtain the non-uniform background illumina-
tion pattern. Further, images were filtered using an aniso-
tropic diffusion filtering technique [25] which is a non-
uniform filtering approach that preserves the image sharp-
ness and removes the noise. The cells were segmented
from the background using a Markov Random Field based
segmentation technique [26] The total cell and well area
(pixels), total green intensity within the cell regions were
calculated and saved into an ASCII file in tab-delimited
format for further processing. The graphical user interface
(GUI) that integrates the whole process was implemented
in MATLAB (The Mathworks, Inc., Natick, MA, USA) pro-
gramming environment, and the 96-images were proc-
essed in batch mode.
Data are presented as Mean ± SEM of total fluorescence
intensity in each well with replicate readings ranging from
three to eight as indicated in the text. Student t'test was
used when comparing two data groups while analysis of
variance (ANOVA) was performed for each data set having
three or more data groups.
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